sulforaphane has been researched along with Bipolar Disorder in 1 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
Bipolar Disorder: A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Any adverse events will be recorded throughout the trial." | 1.56 | The efficacy and safety of sulforaphane as an adjuvant in the treatment of bipolar depressive disorder: Study protocol for a randomized, double-blinded, placebo-controlled, parallel-group clinical trial. ( Chen, X; Hu, S; Lai, J; Wu, C; Xu, Y, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, C | 1 |
| Chen, X | 1 |
| Lai, J | 1 |
| Xu, Y | 1 |
| Hu, S | 1 |
1 other study available for sulforaphane and Bipolar Disorder
| Article | Year |
|---|---|
The efficacy and safety of sulforaphane as an adjuvant in the treatment of bipolar depressive disorder: Study protocol for a randomized, double-blinded, placebo-controlled, parallel-group clinical trial.
Topics: Adjuvants, Pharmaceutic; Adult; Antipsychotic Agents; Bipolar Disorder; Clinical Protocols; Double-B | 2020 |